Emergent Biosolutions (EBS) Reports Q2 Loss of $0.17

August 6, 2007 4:37 PM EDT Send to a Friend

Emergent Biosolutions (NYSE: EBS) reported Q2 loss ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Emergent Biosolutions (EBS) Reports Q2 Loss of $0.17

Member Login

Free News Feed